Omicron's feeble attack on the lungs could make it less dangerous

@article{Kozlov2022OmicronsFA,
  title={Omicron's feeble attack on the lungs could make it less dangerous},
  author={Max Kozlov},
  journal={Nature},
  year={2022}
}
Mounting evidence from animal studies suggests that Omicron does not multiply readily in lung tissue, which can be badly damaged in people infected with other variants. Mounting evidence from animal studies suggests that Omicron does not multiply readily in lung tissue, which can be badly damaged in people infected with other variants. 
Can the Omicron variant of COVID‐19 cause pneumonia in young patients without risk factors?
TLDR
A case of COVID‐19 pneumonia by the Omicron variant in young patients without obvious risk factors is presented and it is shown that pneumonia does not often appear as a complication of this coronavirus variant.
OMICRON-ASSOCIATED CHANGES IN SARS-COV-2 SYMPTOMS IN THE UNITED KINGDOM
TLDR
Increases in sore throat, and the marked reduction in the previously highest specificity symptoms, namely loss of taste/smell, mean Omicron is harder to detect with symptom-based testing algorithms.
Is Omicron the end of pandemic or start of a new innings?
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
TLDR
It is shown that SARS-CoV-2 Omicron virus isolates display enhanced sensitivity to interferon treatment, which makes interferons promising therapy candidates for Omicrons patients, in particular in combination with other antiviral agents.
Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review
TLDR
The latest publication and the most recent available literature on the Omicron variant are reviewed, enlightening both reasons for concern and high hopes for new therapeutic strategies.
The COVID-19 pandemic — what have urologists learned?
TLDR
The authors describe the current knowledge of the consequences of SARS-CoV-2 infection on the urogenital system, discussing urological symptoms and damage to organs of the genitourinary tract induced by COVID-19 infection.
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
TLDR
The results are as percentage inhibition relative to virus which received no drug and addition Bioreader 7000-F-Z-I microplate (Biosys).
Application of Monoclonal Antibody Drugs in Treatment of COVID-19: a Review
TLDR
Results of preliminary studies showed that immunosuppressive therapy, such as interleukin (IL)-6, IL-1, and TNF-α antagonists commonly used in rheumatology, can be considered as treatment options for COVID-19, especially in severe cases.
Edible formulations of chicken egg derived IgY antibodies neutralize SarsCoV2 Omicron RBD binding to human ACE2
TLDR
This work has developed chicken egg derived anti-RBD IgY antibodies that neutralize the binding of Omicron RBD to human ACE2 and formulated the edible IgY as flavored beverages to allow for use as oral rinse and prevent the entry of O Micron in the oropharyngeal passage.
...
...

References

SHOWING 1-6 OF 6 REFERENCES
Reduced Pathogenicity of the SARS-CoV-2 Omicron Variant in Hamsters
TLDR
It is shown that Omicron is less pathogenic than prior SARS-CoV-2 variants in Syrian golden hamsters and may result in more robust upper respiratory tract infection but less severe lower respiratory tract clinical disease compared with prior SATS variants.
The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry
TLDR
It is shown Omicron replicates rapidly in human primary airway cultures, more so even than the previously dominant variant of concern, Delta, and is posited to be more infectious at lower exposure doses, and resulting in enhanced intrinsic transmissibility.
SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19
TLDR
Animal model data suggest the clinical consequences of infection with the Omicron variant may be less severe but the higher transmissibility could still place huge burden upon healthcare systems even if a lower proportion of infected patients are hospitalised.
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters
TLDR
Impaired lung disease in rodents is observed in wild-type and hACE2 transgenic hamsters, which parallels preliminary human clinical data, and experiments from multiple independent laboratories of the SAVE/NIAID network with several different B.1.1-CoV-2 isolates demonstrate attenuated lung diseases in rodents.
SARS-CoV-2 Omicron spike mediated immune escape, infectivity and cell-cell fusion
TLDR
It is shown that the Omicron spike confers very significant evasion of vaccine elicited neutralising antibodies that is more pronounced for ChAdOx-1 adenovirus vectored vaccine versus BNT162b2 mRNA vaccine.
The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism
TLDR
It is shown that immunity from natural infection (without vaccination) is more protective than two doses of vaccine but inferior to three doses, and fundamental changes in the Omicron entry process in vitro, towards TMPRSS2-independent fusion, representing a major shift in the replication properties of SARS-CoV-2.